AMCase deficiency leads to age-dependent pulmonary chitin accumulation and causes increased ILC2 responses and pulmonary fibrosis, whereas transgenic AMCase overexpression results in resistance to chitin-dependent type 2 inflammation, demonstrating that degradation of insoluble polysaccharide chitin by AMCase is protective [35, 62]. Here, CHIA is linked to pulmonary fibrosis.